FDA Inspection 1006775 — Coherus Oncology, Inc.
The FDA completed an inspection of Coherus Oncology, Inc. on March 16, 2017 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Redwood City, CA (United States)